MILAN, Italy — Ananta Medicare took part in the main international pharmaceutical event of the year — the CPhI Worldwide 2026 exhibition, which has traditionally become the birthplace of new opportunities and strategic prospects.

This year, Milan turned into a large-scale platform for hundreds of important meetings. The international business development team of Ananta Medicare, united by a shared vision of the future of the pharmaceutical industry, held a series of successful negotiations, laying the foundation for long-term cooperation with foreign partners.

The focus of attention of visitors and experts was the company's portfolio of innovative and generic products. Every presented solution demonstrated impeccable quality and opened the way to entering new global markets. Today, Ananta Medicare manufactures high-quality products at its own 8 pharmaceutical plants, which hold authoritative international certificates of compliance, including EU GMP, Health Canada GMP, PIC/S GMP and others.

Ananta Medicare continues to move confidently forward, creating the future of medicine together with partners around the world.